BRIEF published on 09/19/2024 at 14:35, 1 year 2 months ago Lehman Brothers UK Cap Fdg V LP: Notice to the Holders of the Preferred Securities Liquidation Investor Information Financial Notice Lehman Brothers Preferred Securities
BRIEF published on 09/19/2024 at 14:35, 1 year 2 months ago Lehman Brothers UK Cap Fdg V LP : Avis aux détenteurs de titres privilégiés Liquidation Informations Pour Les Investisseurs Avis Financier Lehman Brothers Titres Privilégiés
PRESS RELEASE published on 09/19/2024 at 14:30, 1 year 2 months ago Lehman Brothers UK Cap Fdg V LP: Notice to the Holders of the Preferred Securities Lehman Brothers UK Cap Fdg V LP issues a notice to holders of preferred securities, providing important information. Joint liquidator RSM UK Restructuring Advisory LLP publishes formal notice Lehman Brothers Preferred Securities UK Cap Fdg V LP Formal Notice RSM UK
PRESS RELEASE published on 09/21/2023 at 18:00, 2 years 2 months ago Notice to the Holders of the Preferred Securities
Published on 12/05/2025 at 02:35, 4 hours 4 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 39 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 34 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 39 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 8 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 48 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 13 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 24 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 28 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:14, 12 hours 24 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 12 hours 39 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 12 hours 39 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 54 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 12 hours 54 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
